Autologous Vaccination for the Treatment of Equine Sarcoids: 18 Cases (2009-2014)

Overview

Journal Can Vet J

Specialty Veterinary Medicine

Date 2015 Jul 2

PMID 26130832

Citations 7

Authors

Caitlin C Rothacker

Ashley G Boyle

David G Levine

Affiliations

Soon will be listed here.

Abstract

The purpose of this retrospective case series was to assess the outcome of an autologous vaccination procedure on single and multiple sarcoid lesions, determine complication rate, and report owner satisfaction. Medical records (18 cases) from January 2009 through May 2014 were evaluated to identify horses undergoing the procedure. Signalment, number, size, anatomic location of lesions, and type of historical treatment were recorded. Follow-up was obtained via standardized owner survey, veterinary examination, and digital images. Data recorded and analyzed included ancillary therapies post-procedure, decrease in number and/or size of sarcoid lesions, sarcoid regrowth, complications, and owner satisfaction. There was a decrease in number of lesions observed by owners in 75% of cases and a decrease in size of sarcoids in 93.8% of cases. Clinical regression observed by owners was noted in 68.8% of cases. There were complications in 43.8% of cases and owner satisfaction in 75% of cases.

Citing Articles

Extensive intraocular melanoma with secondary glaucoma in a 15-month-old Thoroughbred filly.

Pereira R, Gillespie S, Rapezzano G, Withers J, Duz M, Foote A Vet Med Sci. 2024; 10(3):e1471.

PMID: 38739097 PMC: 11090147. DOI: 10.1002/vms3.1471.

A randomized placebo-controlled double-blinded study comparing oral and subcutaneous administration of mistletoe extract for the treatment of equine sarcoid disease.

Beermann A, Clottu O, Reif M, Biegel U, Unger L, Koch C J Vet Intern Med. 2024; 38(3):1815-1824.

PMID: 38529853 PMC: 11099770. DOI: 10.1111/jvim.17052.

Immunotherapy of Equine Sarcoids-From Early Approaches to Innovative Vaccines.

Jindra C, Hainisch E, Brandt S Vaccines (Basel). 2023; 11(4).

PMID: 37112681 PMC: 10145708. DOI: 10.3390/vaccines11040769.

ALVAC-fIL2, a feline interleukin-2 immunomodulator, as a treatment for sarcoids in horses: A pilot study.

Saba C, Eggleston R, Parks A, Peroni J, Sjoberg E, Rice S J Vet Intern Med. 2022; 36(3):1179-1184.

PMID: 35416353 PMC: 9151478. DOI: 10.1111/jvim.16425.

Influenza virus vector iNS1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients.

Jindra C, Hainisch E, Rummele A, Wolschek M, Muster T, Brandt S PLoS One. 2021; 16(11):e0260155.

PMID: 34797850 PMC: 8604313. DOI: 10.1371/journal.pone.0260155.

References

van Poelgeest M, Welters M, van Esch E, Stynenbosch L, Kerpershoek G, van Persijn van Meerten E . HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial. J Transl Med. 2013; 11:88. PMC: 3623745. DOI: 10.1186/1479-5876-11-88. View

Paillot R . A systematic review of the immune-modulators Parapoxvirus ovis and Propionibacterium acnes for the prevention of respiratory disease and other infections in the horse. Vet Immunol Immunopathol. 2013; 153(1-2):1-9. DOI: 10.1016/j.vetimm.2013.01.010. View

Vici P, Mariani L, Pizzuti L, Sergi D, Di Lauro L, Vizza E . Immunologic treatments for precancerous lesions and uterine cervical cancer. J Exp Clin Cancer Res. 2014; 33:29. PMC: 3986944. DOI: 10.1186/1756-9966-33-29. View

Meredith D, Elser A, Wolf B, Soma L, Donawick W, Lazary S . Equine leukocyte antigens: relationships with sarcoid tumors and laminitis in two pure breeds. Immunogenetics. 1986; 23(4):221-5. DOI: 10.1007/BF00373016. View

Vanselow B, Abetz I, Jackson A . BCG emulsion immunotherapy of equine sarcoid. Equine Vet J. 1988; 20(6):444-7. DOI: 10.1111/j.2042-3306.1988.tb01571.x. View

Theon A, Pascoe J, Carlson G, Krag D . Intratumoral chemotherapy with cisplatin in oily emulsion in horses. J Am Vet Med Assoc. 1993; 202(2):261-7. View

Theon A, Pascoe J . Iridium-192 interstitial brachytherapy for equine periocular tumours: treatment results and prognostic factors in 115 horses. Equine Vet J. 1995; 27(2):117-21. DOI: 10.1111/j.2042-3306.1995.tb03046.x. View

Baier M, Werner A, Bannert N, Metzner K, Kurth R . HIV suppression by interleukin-16. Nature. 1995; 378(6557):563. DOI: 10.1038/378563a0. View

Kinnunen R, Tallberg T, Stenback H, Sarna S . Equine sarcoid tumour treated by autogenous tumour vaccine. Anticancer Res. 2000; 19(4C):3367-74. View

10.

Rush B, Flaminio M . Immunomodulation in horses. Vet Clin North Am Equine Pract. 2000; 16(1):183-97, viii. DOI: 10.1016/s0749-0739(17)30126-8. View

11.

Delves P, Roitt I . The immune system. First of two parts. N Engl J Med. 2000; 343(1):37-49. DOI: 10.1056/NEJM200007063430107. View

12.

Martens A, De Moor A, Demeulemeester J, Ducatelle R . Histopathological characteristics of five clinical types of equine sarcoid. Res Vet Sci. 2000; 69(3):295-300. DOI: 10.1053/rvsc.2000.0432. View

13.

Carr E, Theon A, Madewell B, Hitchcock M, Schlegel R, Schiller J . Expression of a transforming gene (E5) of bovine papillomavirus in sarcoids obtained from horses. Am J Vet Res. 2001; 62(8):1212-7. DOI: 10.2460/ajvr.2001.62.1212. View

14.

Chambers G, Ellsmore V, OBrien P, Reid S, Love S, Campo M . Association of bovine papillomavirus with the equine sarcoid. J Gen Virol. 2003; 84(Pt 5):1055-1062. DOI: 10.1099/vir.0.18947-0. View

15.

Lavach J, Sullins K, Roberts S, SEVERIN G, Wheeler C, Lueker D . BCG treatment of periocular sarcoid. Equine Vet J. 1985; 17(6):445-8. DOI: 10.1111/j.2042-3306.1985.tb02552.x. View

16.

Nogueira S, Torres S, Malone E, Diaz S, Jessen C, Gilbert S . Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: a pilot study. Vet Dermatol. 2006; 17(4):259-65. DOI: 10.1111/j.1365-3164.2006.00526.x. View

17.

Theon A, Wilson W, Magdesian K, Pusterla N, Snyder J, Galuppo L . Long-term outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in equidae: 573 cases (1995-2004). J Am Vet Med Assoc. 2007; 230(10):1506-13. DOI: 10.2460/javma.230.10.1506. View

18.

Ashrafi G, Piuko K, Burden F, Yuan Z, Gault E, Muller M . Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1. J Gen Virol. 2007; 89(Pt 1):148-157. DOI: 10.1099/vir.0.83267-0. View

19.

Nasir L, Campo M . Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids. Vet Dermatol. 2008; 19(5):243-54. DOI: 10.1111/j.1365-3164.2008.00683.x. View

20.

Finlay M, Yuan Z, Burden F, Trawford A, Morgan I, Campo M . The detection of Bovine Papillomavirus type 1 DNA in flies. Virus Res. 2009; 144(1-2):315-7. DOI: 10.1016/j.virusres.2009.04.015. View